Home Newsfeeds Raymond James Downgrades Radius Global Infr to Underperform

Raymond James Downgrades Radius Global Infr to Underperform

Raymond James analyst Ric Prentiss downgrades Radius Global Infr (NASDAQ:RADI) from Strong Buy to Underperform.

byBenzinga Newsdesk

March 3, 2023

1 minute read

Raymond James analyst Ric Prentiss downgrades Radius Global Infr (NASDAQ:RADI) from Strong Buy to Underperform.

Piper Sandler Maintains Neutral on Itron, Raises Price Target to $58

By Benzinga Newsdesk

February 28, 9:37 AM

Piper Sandler analyst Kashy Harrison maintains Itron (NASDAQ:ITRI) with a Neutral and raises the price target from $48 to $58.

ITRI

Aileron Therapeutics Announces Termination Of Phase 1b Breast Cancer Chemoprotection Trial And Exploration Of Strategic Alternatives

By Bill Haddad

February 21, 9:41 AM

Aileron Therapeutics (NASDAQ:ALRN) today announced that a review of initial data from its Phase 1b chemoprotection trial of ALRN-6924 in patients with p53-mutated breast cancer showed that patients in the trial

ALRN

Get Ready: ‘Recession Very Likely’ According To BofA’s 2023 Market Outlook

By Wayne Duggan

November 21, 12:57 PM

Bank of America released its 2023 global economic outlook report on Sunday, and the firm's economists are anticipating recessions in the U.S., Europe and the U.K. in the coming year.

SPY